Ensysce Biosciences

Ensysce Biosciences is a clinical-stage pharmaceutical company dedicated to addressing the prescription drug abuse epidemic. They are developing innovative solutions for severe pain relief that minimize the risk of drug abuse and overdose. Ensysce's two key technology platforms, TAAP™ and MPAR®, are designed to improve patient care while reducing the human and economic costs associated with prescription drug abuse. TAAP™ is a tamper-proof technology that ensures drugs are only activated when swallowed, while MPAR® provides overdose protection by inhibiting activation if too much medication is taken.

Ensysce has a strong focus on clinical development, with a pipeline of products that are being evaluated for their safety and efficacy in clinical trials. Their lead product, PF614, is an oxycodone-based pain medication that has been chemically modified to be abuse-resistant. PF614-MPAR®, a combination product of PF614 and MPAR®, is designed to provide overdose protection as well. Ensysce's innovative approach and commitment to addressing the opioid crisis make them a promising company in the pharmaceutical industry.

Ensysce Biosciences is a clinical-stage pharmaceutical company dedicated to revolutionizing the safety of oral drug delivery, particularly in areas with high unmet needs like pain management. Their proprietary TAAP™ and MPAR® technologies prevent drug abuse and overdose, respectively, by using a unique, tamper-proof approach that activates and releases medication only when it is swallowed and comes into contact with the natural digestive enzyme trypsin. Ensysce's mission is to improve patient care by delivering innovative, safe, and effective prescription drugs that minimize the risks associated with abuse and overdose.

Ensysce Biosciences promotes a culture of innovation and collaboration, fostering a team environment where brilliant minds with diverse backgrounds come together to tackle the prescription drug abuse epidemic. The company emphasizes a focus on chemistry and advanced technology, while remaining driven by a mission to improve patient care and safety through safer, more effective drug delivery solutions.

Ensysce Biosciences is committed to fostering a diverse, equitable, and inclusive work environment. They recognize the value of diverse perspectives and experiences, and strive to create an environment where everyone feels respected, valued, and empowered to contribute their best. The company actively recruits, retains, and promotes individuals from all backgrounds and identities. They also provide ongoing training and development opportunities to ensure all employees have the skills and knowledge needed to thrive. This dedication to building a diverse and inclusive workplace is essential to the success of Ensysce Biosciences and its mission to stem the prescription drug abuse epidemic.